Evidence map›Paper›PMID 41307133›Full record

ArticleHaematologica2026

Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphoma.

Adam J Olszewski, Thomas A Ollila, Dai Chihara, Geoffrey Shouse, Natalie Grover, Reem Karmali, Pallawi Torka, Colin Thomas, Praveen Ramakrishnan Geethakumari, Stefan K Barta and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Adam J OlszewskiDepartment of Medicine, Warren Alpert Medical School of Brown University, Providence, RI. adam_olszewski@brown.edu.
Thomas A OllilaDepartment of Medicine, Warren Alpert Medical School of Brown University, Providence, RI.
Dai ChiharaDepartment of Lymphoma - Myeloma, MD Anderson Cancer Center, Houston, TX.
Geoffrey ShouseDepartment of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.
Natalie GroverDivision of Hematology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC .
Reem KarmaliDepartment of Medicine, Northwestern University, Chicago, IL .
Pallawi TorkaRoswell Park Comprehensive Cancer Center, Buffalo, NY, USA; Department of Medicine,Memorial Sloan Kettering Cancer Center, New York, NY.
Colin ThomasDivision of Hematology, Thomas Jefferson University, Philadelphia, PA, USA; Department of Medicine, University of Pennsylvania, Philadelphia, PA.
Praveen Ramakrishnan GeethakumariHarold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX.
Stefan K BartaDepartment of Medicine, University of Pennsylvania, Philadelphia, PA.
Nancy L BartlettSiteman Cancer Center, Washington University School of Medicine, St. Louis, MO.
Narendranath EpperlaHuntsman Cancer Institute, University of Utah, Salt Lake City, UT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41307133
PMCPMC13136822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.